Related Experiment Video

Updated: Aug 9, 2026

Studying Proteolysis of Cyclin B at the Single Cell Level in Whole Cell Populations
10:54

Studying Proteolysis of Cyclin B at the Single Cell Level in Whole Cell Populations

Published on: September 17, 2012

Interaction with cyclin-dependent kinases and PCNA modulates proteasome-dependent degradation of p21

C Cayrol1, B Ducommun

  • 1I.P.B.S.-C.N.R.S Université Paul Sabatier, Toulouse, France.

Oncogene
|November 21, 1998
PubMed

Insights

The cell proliferation regulator p21 (also known as cyclin-dependent kinase inhibitor 1 or Cip1/Waf1) is degraded by proteasomes, but PCNA binding stabilizes it. High p21 levels override this degradation.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Cancer Research

Background:

  • p21 (cyclin-dependent kinase inhibitor 1) is crucial for cell cycle control.
  • Its function as an inhibitor or assembly factor depends on expression levels.
  • Understanding p21 regulation is vital for cancer therapy.

Purpose of the Study:

  • To investigate the mechanisms controlling p21 protein stability and abundance.
  • To elucidate the roles of proteasomal degradation and protein interactions in p21 regulation.

Main Methods:

  • Utilized a tetracycline-regulated system in p53-deficient DLD-1 colon cancer cells.
  • Created and analyzed p21 mutants defective for CDK or PCNA interaction.
  • Assessed p21 protein levels, stability, and sensitivity to proteasomal degradation.

Main Results:

  • p21 protein levels and stability are regulated by proteasome-dependent degradation.
  • Association with cyclin/CDK complexes promotes p21 degradation.
  • Interaction with PCNA protects p21 from proteasomal degradation.
  • High p21 expression levels can overcome proteasome-mediated regulation.

Conclusions:

  • p21 stability is dynamically regulated by its interactions with CDKs and PCNA.
  • Proteasomal degradation is a key mechanism controlling p21 abundance.
  • PCNA binding stabilizes p21, while CDK binding promotes its degradation.

More Related Videos

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors10:33

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors

Published on: October 26, 2015

Identification of Cyclin-dependent Kinase 1 Specific Phosphorylation Sites by an In Vitro Kinase Assay12:26

Identification of Cyclin-dependent Kinase 1 Specific Phosphorylation Sites by an In Vitro Kinase Assay

Published on: May 3, 2018

Related Concept Videos

Positive Regulator Molecules01:45

Positive Regulator Molecules

To consistently produce healthy cells, the cell cycle—the process that generates daughter cells—must be precisely regulated.
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Positive Regulator Molecules02:39

Positive Regulator Molecules

Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Anaphase Promoting Complex00:50

Anaphase Promoting Complex

The stepwise destruction of specific proteins is necessary for the progression and completion of the cell cycle. Such proteins are ubiquitinated by ubiquitin ligases and then subsequently destroyed by the proteasome. The SCF (Skp1/Cullin/F-box) and the anaphase-promoting complex (APC) are two important ubiquitin ligases involved in cell cycle progression. While SCF is active throughout the cell cycle, APC gets activated during metaphase to anaphase transition. Cdc20 or Cdh1 binds to APC and...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...